Stay updated with breaking news from Crispr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Last year, Verve Therapeutics started the first human trial of a CRISPR treatment that could benefit most people—a signal that gene editing may be ready to go mainstream.
Gene therapy takes a giant leap forward as Exa-cel becomes the world’s first CRISPR/Cas9 gene-edited therapy approved to treat sickle cell disease and thalassemia.
:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/irishtimes/ZIBDK4ELEO3MICPBNNLYGE6CKA.jpg)
Treatment offers relief and possibly a cure for patients with sickle cell disease and one other blood ailment
The companies changing our phones, our media and our meat.
Microbubbles were used to deliver CRISPR tools to the liver to inhibit a gene that increases cardiovascular risk.